Immunologic Research

, Volume 38, Issue 1–3, pp 191–200 | Cite as

Matched unrelated bone marrow transplant for severe combined immunodeficiency

  • Chaim M. Roifman
  • Eyal Grunebaum
  • Ilan Dalal
  • Luigi Notarangelo
Article

Abstract

Severe combined immunodeficiency (SCID) is a lethal disease unless allogeneic bone marrow transplantation (BMT), preferably from a family related HLA identical donor (RID) is given. Previously, some patients received HLA-mismatched related donors (MMRD) BMT, which often resulted in slow immune reconstitution and variable survival. Alternatively, HLA-matched unrelated donors (MUD) BMT have been suggested. Recently, we have directly compared outcome of patients with SCID who received either MMRD or MUD BMT. Survival after MUD BMT was significantly better than after MMRD BMT. Patients who received MUD BMT also had better engraftment of donor cells and immune reconstitution. Recent reports from other centers confirm these results finding that MUD BMT provides excellent survival and better immune reconstitution for patients with SCID. In conclusion, MUD BMT appears vastly superior to MMRD BMT and should be offered as first choice of treatment for patients with SCID when RID is unavailable.

Keywords

Bone marrow transplant Matched unrelated severe combined immunodeficiency T+ SCID 

References

  1. 1.
    Huang H, Manton KG. Newborn screening for severe combined immunodeficiency (SCID): a review. Front Biosci 2005;10:1024–39.PubMedCrossRefGoogle Scholar
  2. 2.
    Fischer A, Landais P, Friedrich W, et al. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 1990;336:850–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Haddad E, Landais P, Friedrich W, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998;91:3646–53.PubMedGoogle Scholar
  4. 4.
    Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 2004;22:625–55.PubMedCrossRefGoogle Scholar
  5. 5.
    Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 2003;361:553–60.PubMedCrossRefGoogle Scholar
  6. 6.
    Caillat-Zucman S, Le Deist F, Haddad E, et al. Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-centre comparative analysis of genoidentical, haploidentical or unrelated donors. Bone Marrow Transplant 2004;33:1089–95.PubMedCrossRefGoogle Scholar
  7. 7.
    Cavazzana-Calvo M, Andre-Schmutz I, Hacein-Bey-Abina S, Bensoussan D, Le Deist F, Fischer A. Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation. Semin Hematol 2002;39:32–40.PubMedCrossRefGoogle Scholar
  8. 8.
    Amrolia PJ, Muccioli-Casadei G, Yvon E, et al. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood 2003; 102:2292–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Ball LM, Lankester AC, Bredius RG, Fibbe WE, van Tol MJ, Egeler RM. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation. Bone Marrow Transplant 2005;35(suppl 1):S35–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Patel DD, Gooding ME, Parrott RE, Curtis KM, Haynes BF, Buckley RH. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 2000;342:1325–32.PubMedCrossRefGoogle Scholar
  11. 11.
    Arpaia E, Shahar M, Dadi H, et al. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking Zap-70 kinase. Cell 1994;76:947–58.PubMedCrossRefGoogle Scholar
  12. 12.
    Sharfe N, Dadi HK, Shahar M, et al. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 1997;94:3168–71.PubMedCrossRefGoogle Scholar
  13. 13.
    Alarcon B, Regueiro JR, Arnaiz-Villena A, et al. familial defect in the surface of expression of the T-cell receptor CD3 complex. New Engl J Med 1988;319:1203–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Sharfe N, Shahar M, Roifman CM. An interleukin-2 receptor γ chain mutation with normal thymus morphology. J Clin Invest 1997;100:3036–3043. December 7, 2006 15.PubMedCrossRefGoogle Scholar
  15. 15.
    Notarangelo LD, Giliani S, Mazza C, Mella P, Savoldi G, Rodriguez-Perez C, et al. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma©-JAK3 signaling pathway as a model. Immunol Rev 2000;178:39–48.PubMedCrossRefGoogle Scholar
  16. 16.
    Somech R, Roifman CM. Mutation analysis should be performed to rule out γc deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests. J Pediatr 2005;147:555–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Roifman CM. Studies of Patients’ Thymi aid in the discovery and characterization of immunodeficiency in humans. In: Koretzky G, Monroe J, editors. Immunological reviews. Vol. 203. Singapore: Blackwell Munksguard; 2005. p. 143–55.Google Scholar
  18. 18.
    Zhang J, Quintal L, Atkinson A, Williams B, Grunebaum E, Roifman CM. Novel RAG1 mutation in a case of severe combined immunodeficiency. Pediatrics 2005;116:e445–59.PubMedCrossRefGoogle Scholar
  19. 19.
    Roifman CM, Gu Y, Cohen A. Mutations in the RNA component of Rnase MRP cause Omenn Syndrome. J Allergy Clin Immunol 2006; 117:897–903.PubMedCrossRefGoogle Scholar
  20. 20.
    Hirschhorn R. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediatr Res 1993;3(Suppl):S35–41.CrossRefGoogle Scholar
  21. 21.
    Fischer A, Griscelli F, Friedrich W, et al. Bone marrow transplantation for immunodeficiencies and osteopetrosis: European survey: 1968–1985. Lancet 1986;2:1080–3.PubMedCrossRefGoogle Scholar
  22. 22.
    O’Reilly RJ, Dupont B, Pahwa S, et al. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 1977;297:1311–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Dalal I, Reid B, Doyle J, et al. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplant 2000;25:613–21.PubMedCrossRefGoogle Scholar
  24. 24.
    Filipovich AH, Shapiro RS, Ramsay NK, et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood 1992;80:270–6.PubMedGoogle Scholar
  25. 25.
    Buckley RH, Schiff SE, Schiff RI, et al. hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999;340:508–16.PubMedCrossRefGoogle Scholar
  26. 26.
    Buckley RH. Advances in the understanding and treatment of human severe combined immunodeficiency. Immunol Res 2000;22:237–51.PubMedCrossRefGoogle Scholar
  27. 27.
    Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002;8:257–60.PubMedCrossRefGoogle Scholar
  28. 28.
    Anasetti C, Petersdorf EW, Martin PJ, Woolfrey A, Hansen JA. Trends in transplantation of hematopoietic stem cells from unrelated donors. Curr Opin Hematol 2001;8:337–41.PubMedCrossRefGoogle Scholar
  29. 29.
    Stroncek D, Bartsch G, Perkins HA, Randall BL, Hansen JA, McCullough J. The National Marrow Donor Program. Transfusion 1993;33:567–77.PubMedCrossRefGoogle Scholar
  30. 30.
    Tiercy JM, Bujan-Lose M, Chapuis B, et al. Bone marrow transplantation with unrelated donors: what is the probability of identifying and HLA-A/B/CwDRB1/B3/B5/DQB1-matched donor?. Bone Marrow Transplant 2000;26:437–41.PubMedCrossRefGoogle Scholar
  31. 31.
    Candusso M, Faraguna D, Landini P. Artificial nutrition and bone marrow transplantation. Haematologica 2000;85:58–61.PubMedGoogle Scholar
  32. 32.
    Drobyski WR, Klein J, Fmomeberg N, et al. Superior survival associated with transplantation of matched unrelated versus one-antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood 2002;99:806–14.PubMedCrossRefGoogle Scholar
  33. 33.
    Lanfranchi A, Verardi R, Tettoni K, et al. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency. Haematologica 2000;85:41–6.PubMedGoogle Scholar
  34. 34.
    Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, Notarangelo L, Roifman CM. Bone Marrow transplantation for severe combined immune deficiency. JAMA 2006;295:508–18.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Chaim M. Roifman
    • 1
  • Eyal Grunebaum
    • 1
  • Ilan Dalal
    • 1
  • Luigi Notarangelo
    • 2
  1. 1.Division of Immunology and Allergy and Infection, Immunity, Injury and Repair Program, The Canadian Centre for Primary Immunodeficiency, The Jeffrey Modell Research Laboratory for the diagnosis of Primary ImmunodeficiencyThe Hospital for Sick Children and The University of TorontoTorontoCanada
  2. 2.The Department of Pediatrics, The Angelo Nociveli Institute for Molecular MedicineUniversity of Brescia Spedali CiviliBresciaItaly

Personalised recommendations